Marshall Wace LLP Has $5.95 Million Stock Position in Afya Limited (NASDAQ:AFYA)

Marshall Wace LLP boosted its stake in Afya Limited (NASDAQ:AFYA - Free Report) by 41.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 336,985 shares of the company's stock after buying an additional 99,416 shares during the period. Marshall Wace LLP owned 0.36% of Afya worth $5,948,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Lifestyle Asset Management Inc. lifted its stake in shares of Afya by 26.9% in the 2nd quarter. Lifestyle Asset Management Inc. now owns 14,784 shares of the company's stock worth $261,000 after acquiring an additional 3,133 shares during the period. Campbell & CO Investment Adviser LLC boosted its stake in Afya by 56.6% during the 4th quarter. Campbell & CO Investment Adviser LLC now owns 28,608 shares of the company's stock valued at $627,000 after purchasing an additional 10,337 shares in the last quarter. Dodge & Cox boosted its stake in Afya by 7.0% during the 4th quarter. Dodge & Cox now owns 29,183 shares of the company's stock valued at $640,000 after purchasing an additional 1,900 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Afya by 19.7% during the 2nd quarter. Renaissance Technologies LLC now owns 266,500 shares of the company's stock valued at $4,704,000 after purchasing an additional 43,800 shares during the period. Finally, Doma Perpetual Capital Management LLC bought a new stake in shares of Afya in the 4th quarter worth $6,467,000. 88.02% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on AFYA shares. UBS Group began coverage on Afya in a report on Friday, August 30th. They set a "neutral" rating and a $19.50 target price on the stock. Morgan Stanley lowered their price objective on shares of Afya from $21.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, June 21st.

Afya Price Performance

Shares of NASDAQ AFYA traded up $0.22 during mid-day trading on Tuesday, reaching $17.29. The company had a trading volume of 100,281 shares, compared to its average volume of 132,920. The company has a 50-day moving average price of $17.21 and a two-hundred day moving average price of $17.59. The stock has a market cap of $1.62 billion, a PE ratio of 15.82, a P/E/G ratio of 0.45 and a beta of 0.92. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.40. Afya Limited has a 1-year low of $14.57 and a 1-year high of $22.48.

Afya (NASDAQ:AFYA - Get Free Report) last issued its quarterly earnings results on Thursday, August 15th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.06. The firm had revenue of $155.40 million for the quarter, compared to analysts' expectations of $151.83 million. Afya had a return on equity of 18.82% and a net margin of 18.12%. On average, equities analysts anticipate that Afya Limited will post 1.52 earnings per share for the current year.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.